Abstract:Background Glutamic acid decarboxylase antibody (GADA) and protein tyrosine phosphatase antibody (IA-2A) are two major autoantibodies, which exert important roles in the process of type 1 diabetes mellitus (T1D). Our study aimed to investigate the changes in positivity and titers of GADA and IA-2A during the course of Chinese acute-onset T1D patients and their relationships with clinical features. Methods Two hundreds and forty-seven Chinese newly diagnosed acute-onset T1D patients were consecutively recruited. GADA and IA-2A were detected at the time of diagnosis, one year later, 3-5 years later after diagnosis during the follow-up; all the clinical data were recorded and analyzed as well. Results During the course of acute-onset T1D, the majority of patients remained stable for GADA or IA-2A, however, a few patients changed from positivity to negativity and fewer patients converted from negativity to positivity. The prevalence of GADA was 56.3% at diagnosis, decreasing to 50.5% one year later, and 43.3% 3-5 years later while the corresponding prevalence of IA-2A were 32.8%, 31.0% and 23.3%, respectively. The median GADA titers were 0.0825 at diagnosis, declining to 0.0585 one year later and 0.0383 3-5 years later (P <0.001), while the corresponding median titers were 0.0016, 0.0010, 0.0014 for IA-2A, respectively. Fasting C-peptide (FCP) and postprandial C-peptide 2 hours (PCP2h) levels of GADA or IA-2A negativity persistence patients were higher than those of positivity persistence and negativity conversion patients (P<0.05) which indicated GADA or IA-2A negativity persistence T1D patients had a less loss of β cell function. Conclusion Our data suggest that repeated detection of GADA and IA-2A are necessary for differential diagnosis of autoimmune diabetes and the indirect prediction of the β cell function in Chinese patients.

The Clinical Efficacy of ICA and GAD-Ab in Diabetes Mellitus

Significance of Glutamic Acid Decarboxylase in Islet Cell Antibody Assay

Significance of combined determination of three autoantibodies in early diagnosis of type 1 diabetes mellitus

[Islet Beta Cell Function in Latent Autoimmune Diabetes in Adults with Islet Cell Antibodies].

Combined Detection of ICA512/IA-2 Antibody in Screening for Autoimmune Mediated Type 1 Diabetes Mellitus

Clinical Value of 4 Islet Autoantibodies in Type 2 Diabetes

Relationship Between Serum Glutamic Acid Decarboxylase Antibody Titer and the First-Phase Insulin Release in Newly-Diagnosed Type 2 Diabetic Patients

The relationship of two subsets of islet cell cytoplasmic autoantibodies to diabetes mellitus

Diagnostic Values of Combining Detection of GADA、ICA and IAA in Type 1 Diabetes Mellitus

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes

Clinical features of type 2 diabetic patients with positive pancreatic auto-antibodies:A meta-analysis

Clinical Evaluation of Autoantibodies to Glutamic Acid Decarboxylase and Islet Cell in the Diagnosis of Iddm

Significance of auto-antibodies against islet cells in the diagnosis of type Ⅰdiabetes

Estimation of Individual Positive Anti-Islet Autoantibodies from 3 Screen ICA Titer

Association Between Serum IL-18 Level and Cytokine in Type 1 Diabetes Mellitus in Children

The prevalence of islet autoantibodies in type 1 diabetes mellitus and its association with disease duration

Comparing the Results of the Determination of Diabetes Autoantibodies with Immunoblotting and ELISA

[A Clinical Analysis of Insulin Antibody in Type 2 Diabetic Patients].

Diagnostic Value of Insulin Autoantibodies for Latent Autoimmune Diabetes in Adults

The autoantibodies of the newly diagnosed diabetic patients in adults

Change of Glutamic Acid Decarboxylase Antibody and Protein Tyrosine Phosphatase Antibody in Chinese Patients with Acute-Onset Type 1 Diabetes Mellitus